IDO/kynurenine pathway in cancer: possible therapeutic approaches

EE Abd El-Fattah - Journal of Translational Medicine, 2022 - Springer
Cancer is one of the leading causes of death in both men and women worldwide. One of the
main changes associated with cancer progression, metastasis, recurrence, and …

The footprint of kynurenine pathway in every cancer: a new target for chemotherapy

M Ala - European Journal of Pharmacology, 2021 - Elsevier
Abstract Treatment of cancers has always been a challenge for physicians. Typically,
several groups of anti-cancer medications are needed for effective management of an …

Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?

C Riess, N Irmscher, I Salewski, D Strüder… - Cancer and Metastasis …, 2021 - Springer
Cyclin-dependent kinases (CDK) control the cell cycle and play a crucial role in
oncogenesis. Pharmacologic inhibition of CDK has contributed to the recent clinical …

Targeting CDK9 for the treatment of glioblastoma

A Ranjan, Y Pang, M Butler, M Merchant, O Kim, G Yu… - Cancers, 2021 - mdpi.com
Simple Summary Inhibition of cyclin-dependent kinase 9 (CDK9) can impact multiple
survival pathways in cancers and may be a promising therapeutic approach for …

The immunotherapeutic role of indoleamine 2, 3‐dioxygenase in head and neck squamous cell carcinoma: A systematic review

DJ Lin, JCK Ng, L Huang, M Robinson… - Clinical …, 2021 - Wiley Online Library
Background Novel cancer immunotherapy seeks to harness the body's own immune system
and tip the balance in favour of antitumour activity. The intracellular enzyme indoleamine 2 …

A pilot study: Metabolic profiling of plasma and saliva samples from newly diagnosed glioblastoma patients

J Muller Bark, AV Karpe, JD Doecke, P Leo… - Cancer …, 2023 - Wiley Online Library
Background Despite aggressive treatment, more than 90% of glioblastoma (GBM) patients
experience recurrences. GBM response to therapy is currently assessed by imaging …

Cancer-associated fibroblasts: Mediators of head and neck tumor microenvironment remodeling

M Raudenska, J Balvan, K Hanelova… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Cancer-associated fibroblasts (CAFs) are involved in critical aspects of head and neck
squamous cell carcinoma (HNSCC) pathogenesis, such as the formation of a tumor …

Kynurenines as a Novel Target for the Treatment of Malignancies

A Mor, A Tankiewicz-Kwedlo, D Pawlak - Pharmaceuticals, 2021 - mdpi.com
Malignancies are unquestionably a significant public health problem. Their effective
treatment is still a big challenge for modern medicine. Tumors have developed a wide range …

Tryptophan 2, 3-dioxygenase may be a potential prognostic biomarker and immunotherapy target in cancer: A meta-analysis and bioinformatics analysis

Y Hu, Z Liu, H Tang - Frontiers in Oncology, 2022 - frontiersin.org
Background Tryptophan 2, 3-dioxygenase (TDO2) is one of the emerging immune
checkpoints. Meanwhile, TDO2 is also a key enzyme in the tryptophan (Trp)–kynurenine …

The tryptophan metabolism, kynurenine pathway and oxidative stress–implications for glioma pathobiology

M Obara-Michlewska - Neurochemistry International, 2022 - Elsevier
The kynurenine pathway receives increasing attention due to its involvement in central
nervous system pathologies, ia neurodegenerative and psychiatric disorders, but also due to …